arrow
G

Gulrayz Ahmed

labahn pancreatic cancer program
H-index:11
Citation Count:475
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

Beyond BRCAness: ATM pathway defects confer sensitivity to topoisomerase I inhibition

超越BRCAness:ATM通路缺陷赋予拓扑异构酶I抑制剂敏感性

2026-09-150
OAAI
Outcomes of Hematopoietic Cell Transplantation in Patients with Plasmablastic Lymphoma

造血细胞移植在浆细胞样淋巴瘤患者中的结局

2026-05-210
PRE
A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings
2025-01-211
OAAI
Unveiling WHIM syndrome: Mavorixafor's emerging role in immune restoration and therapy
2025-01-010
PRE
Reduction in ACE2 expression in peripheral blood mononuclear cells during COVID-19-implications for post COVID-19 conditions
2024-07-031
OAAI
CAR T-cell therapy in mantle cell lymphoma with secondary CNS involvement: a multicenter experience
2024-06-282
OAAI
Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis

嵌合抗原受体T细胞治疗继发性中枢神经系统淋巴瘤的多中心分析

2024-05-203
PRE
Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series

针对KRAS野生型胰腺导管腺癌的融合和驱动突变的无化疗治疗,病例系列

2024-05-191
OAAI
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
2023-08-236
OAAI
Comprehensive genomic profiling: Does timing matter?

全面的基因组分析: 时机重要吗?

2023-02-146
OAAI
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma
2023-02-010
OAAI
CAR T-cell therapy for secondary CNS DLBCL
2021-12-2853
OAAI
Gentian violet - A blessing in disguise for the developing world
BURNS
IF2.9
2013-09-012
PREAI
Weight misperception amongst youth of a developing country: Pakistan -a cross-sectional study
2013-08-0216
OAAI
Cutting down on your Cola drinks
2013-05-080
PREAI